WARF: P120167US01

  • Assigned to WARF as biological material.

Cryopreserved Head and Neck Cancer Tumorgrafts and Related Cell Strains


Paul Lambert, Paul Harari, Randall Kimple, Robert Yang, Alexandra Torres

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in 23 cryopreserved head and neck cancer tumorgrafts and 10 passaged cell strains from a subset of these tumorgrafts.
OVERVIEWTumor xenograft mouse models have been created by injecting human cancer cell lines into immune deficient mice. However, when the effects of various interventions on these models are assessed, the results cannot always be translated to real-life situations.
THE INVENTIONUW–Madison researchers have created a series of tumorgrafts from head and neck cancers, as well as cell lines from a subset of these tumorgrafts. Tumorgrafts are established by grafting human tumor samples directly onto mice and then passaging them onto other mice without ever placing them in tissue culture. They are expected to be more representative of actual human tumors than tumor xenograft mouse models.
  • Assessing response of human tumors to various therapeutic interventions
  • Tumorgrafts may better represent cancer behavior.
  • Many of the tumorgraft samples regrow to form tumors when thawed.
  • Subsets of the tumorgrafts and cell strains have been verified to respond to standard-of-care treatments.
For More Information About the Inventors
Contact Information
For current licensing status, please contact Mark Staudt at or 608-960-9845.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.